Louisiana
Requires Coverage of Comprehensive Biomarker Testing
Only for some plans
Highlighted Disparity
Black individuals in Louisiana are least likely to receive surgical treatment.
Lung Cancer Rates
New Cases:
- The rate of new lung cancer cases is 61.4 and significantly higher than the national rate of 53.6.
- Louisiana ranks 40th among all states, placing it in the below average tier.
- Over the last five years, the rate of new cases improved by 11%.
5-Year Survival Rate:
- The percent of people alive five years after being diagnosed with lung cancer (the survival rate) in Louisiana is 22.9%, which is significantly lower than the national rate of 28.4%.
- It ranks 43rd among the 47 states with survival data, placing it in the bottom tier.
- Over the last five years, the survival rate in Louisiana improved by 27%.
Early Diagnosis:
- 24.3% of cases are caught at an early stage, which is significantly lower than the national rate of 27.4%.
- It ranks 42nd among the 47 states with data on diagnosis at an early stage, placing it in the below average tier.
- Over the last five years, the early diagnosis rate in Louisiana did not change significantly.
Lung Cancer Treatment
Surgical Treatment:
- Louisiana ranked 38th (out of the 47 states with available data) with 16.5% of cases undergoing surgery as part of the first course of treatment.
- This is significantly lower than the national rate of 20.7% and puts Louisiana in the below average tier.
- Over the last five years, the percent of cases undergoing surgery in Louisiana did not change significantly.
Biomarker Coverage:
- Louisiana required some insurance plans to cover comprehensive biomarker testing, including for lung cancer, as of September 2024.
Lack of Treatment:
- Louisiana ranked 35th (out of the 47 states with available data) with 23.2% of cases not receiving any treatment.
- This is significantly higher than the national rate of 20.9% and puts Louisiana in the average tier.
- Over the last five years, the percent of cases receiving no treatment in Louisiana did not change significantly.
Screening
Screening for High Risk:
- In Louisiana, 15.1% of those at high risk were screened, which was not significantly different than the national rate of 16.0%.
- It ranks 30th among all states, placing it in the average tier.
Prevention
Tobacco Use:
- The smoking rate in Louisiana is 16.7% and significantly higher than the national rate of 12.9%.
- It ranks 44th among all states, placing it in the below average tier.
Radon:
- In Louisiana, 3.1% of radon tests results were at or above the action level recommended by EPA.
- It ranks 2nd among all states, placing it in the top tier.
Racial & Ethnic Disparities
Black individuals:
- The rate of new lung cancer cases is 63.4 per 100,000 population among Black individuals in Louisiana, significantly higher than the rate of 55.1 among Black individuals nationally, and not significantly different than the rate of 62.8 among white individuals in Louisiana.
- The five-year survival rate is 20.3% among Black individuals in Louisiana, significantly lower than the rate of 25.5% among Black individuals nationally, and significantly lower than the rate of 23.8% among white individuals in Louisiana.
- 21.7% of lung cancer cases are diagnosed at an early stage among Black individuals in Louisiana, significantly lower than the rate of 24.1% among Black individuals nationally, and significantly lower than the rate of 25.5% among white individuals in Louisiana.
- 13.2% of Black individuals with lung cancer in Louisiana underwent surgery, significantly lower than the rate of 17.0% among Black individuals nationally, and significantly lower than the rate of 17.8% among white individuals in Louisiana.
- 23.7% of Black individuals with lung cancer in Louisiana did not receive any treatment, not significantly different than the rate of 22.7% among Black individuals nationally, and not significantly different than the rate of 23.1% among white individuals in Louisiana.
Latino individuals:
- The rate of new lung cancer cases is 21.1 per 100,000 population among Latino individuals in Louisiana, significantly lower than the rate of 28.1 among Latino individuals nationally, and significantly lower than the rate of 62.8 among white individuals in Louisiana.
- State-level survival rates are not available for Latino individuals at this time. Nationally, the five-year survival rate among Latino individuals is 22.7%, not significantly different than the rate of 25.0% among white individuals.
- 23.4% of lung cancer cases are diagnosed at an early stage among Latino individuals in Louisiana, not significantly different than the rate of 23.5% among Latino individuals nationally, and not significantly different than the rate of 25.5% among white individuals in Louisiana.
- 17.0% of Latino individuals with lung cancer in Louisiana underwent surgery, significantly lower than the rate of 21.3% among Latino individuals nationally, and not significantly different than the rate of 17.8% among white individuals in Louisiana.
- 18.6% of Latino individuals with lung cancer in Louisiana did not receive any treatment, significantly lower than the rate of 26.3% among Latino individuals nationally, and not significantly different than the rate of 23.1% among white individuals in Louisiana.
Asian Americans or Pacific Islanders:
- The rate of new lung cancer cases is 47.0 per 100,000 population among Asian or Pacific Islanders individuals in Louisiana, significantly higher than the rate of 32.5 among Asian or Pacific Islanders individuals nationally, and significantly lower than the rate of 62.8 among white individuals in Louisiana.
- State-level survival rates are not available for Asian or Pacific Islander individuals at this time. Nationally, the five-year survival rate among Asian or Pacific Islander individuals is 28.6% and significantly higher than the rate of 25.0% among white individuals.
- 22.1% of lung cancer cases are diagnosed at an early stage among Asian or Pacific Islander individuals in Louisiana, not significantly different than the rate of 23.4% among Asian or Pacific Islander individuals nationally, and not significantly different than the rate of 25.5% among white individuals in Louisiana.
- 20.1% of Asian or Pacific Islander individuals with lung cancer in Louisiana underwent surgery, not significantly different than the rate of 24.7% among Asian or Pacific Islander individuals nationally, and not significantly different than the rate of 17.8% among white individuals in Louisiana.
- 18.1% of Asian or Pacific Islander individuals with lung cancer in Louisiana did not receive any treatment, not significantly different than the rate of 20.1% among Asian or Pacific Islander individuals nationally, and not significantly different than the rate of 23.1% among white individuals in Louisiana.
Indigenous Peoples:
- The rate of new lung cancer cases is 18.1 per 100,000 population among Indigenous Peoples (American Indians/Alaska Natives) in Louisiana, significantly lower than the rate of 39.9 among Indigenous Peoples nationally, and significantly lower than the rate of 62.8 among white individuals in Louisiana.
- State-level survival rates are not available for Indigenous Peoples at this time. Nationally, the five-year survival rate among Indigenous Peoples is 22.3% and not significantly different than the rate of 25.0% among white individuals.
- Other lung cancer rates are not available for Indigenous Peoples (American Indians/Alaska Natives) in Louisiana due to too few cases over the time period to allow for accurate analysis.
Summary
The early diagnosis rate in Louisiana falls into the below average tier. The state still has a lot of work to do to make sure that more of those at high risk for lung cancer are screened.
Louisiana required some insurance plans to cover comprehensive biomarker testing, which can help determine what treatment options would be best for individuals with lung cancer and other diseases.
Louisiana falls into the average tier for percent of patients receiving no treatment. Some patients do refuse treatment, but issues such as fatalism and stigma can prevent eligible patients from accessing treatment that may save or extend their lives. All patients should work with their doctors to establish a treatment plan and goals.
Page last updated: November 12, 2024